MeSH tree: A15.382
Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anticancer immune response.
9 hours ago
0
4
An international research team led by Dr. Lucia Torres Fernández from the working groups of Professor Dr. Julie George and Professor Dr. Roman Thomas at the University of Cologne has identified a critical dependency in small ...
Sep 9, 2026
0
16
Roughly half the world's population is infected with the stomach bacterium Helicobacter pylori, which is responsible for about 90% of gastric cancers. However, until now, it has been unclear why some H. pylori infections ...
Sep 9, 2026
0
219
When an infection strikes, the immune system produces antibodies to help fight it off. Some antibody responses can protect us for years, while others fade much sooner. Using a mouse model, a team of researchers led by The ...
Sep 9, 2026
0
6
Every fall after school starts, I see an influx of kids with respiratory illnesses. As the weather cools and we spend more time indoors, it is easier for "the crud" to spread quickly.
Sep 8, 2026
0
4
Breast cancer often grows in tissue that is unusually dense. That's why clinicians flag women with this kind of breast tissue for follow-up after a mammogram.
Sep 8, 2026
0
18
Researchers from Cambridge and Basel have developed small molecules that could make cancer immunotherapies more effective. They work in two ways: they prompt macrophages to engulf cancer cells and alter the surrounding tissue, ...
Sep 8, 2026
0
4
University of Manchester scientists have uncovered a hidden role for immune cells in the womb, opening the door to new treatments for infertility, miscarriage and other reproductive conditions that affect millions of women ...
Sep 8, 2026
0
9
CAR T-cell therapy is an immune-reprogramming procedure that turns a patient's own immune cells into cancer-fighting specialists. The entire process is complex, but researchers have now found a faster way to achieve similar ...
New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which are currently being tested as treatments that slow the growth of a narrow range of cancers, could ...
Sep 5, 2026
0
16
